SlideShare a Scribd company logo
Pulmonary system
CYSTIC FIBROSIS (CF)
Cystic fibrosis is a genetic condition. It's caused by a gene mutation in [cystic fibrosis
transmembrane conductance regulatory gene CFTR/ chromosome no.7].
The gene mutation affects the movement of salt and water in and out of cells.
This, along with recurrent infections, can result in a build-up of thick, sticky mucus in
the body's tubes and passageways – particularly the lungs and digestive system.
• Inherited autosomal recessive disorder
• CF incidence of 1:2500 live births
• Survival is improving; median age of patients has exceeded 30 years
• Epithelial cells and exocrine glands secrete abnormal mucus (thick)
• Affects respiratory tract, sweat, salivary, intestine, pancreas, liver, reproductive tract
Organs Affected by Cystic Fibrosis
• Lungs
• Sinus
• Intestines
• Panaceas
• Liver
Symptoms
• The dysfunctional CFTR protein channel is found all over GI tract
• It causes elevated Sweat- Electrolyte balance.
• A persistent cough that produces thick mucus (sputum)
• Wheezing
• Exercise intolerance
• Repeated lung infections
• Inflamed nasal passages or a stuffy nose
• Recurrent sinusitis
DIAGNOSIS OF CYSTIC FIBROSIS
• Neonatal screening provides opportunity to prevent malnutrition in CF
infants
• Sweat test (Na and Cl >60 mEq /L)
• Chronic lung disease
• Malabsorption
• Family history
Complications of CF
• Damaged airways
• Coughing up blood (hemoptysis)
• Chronic infections
• Pneumothorax
• Respiratory failure
NUTRITIONAL IMPLICATIONS OF CF
• Infants born with meconium ileus are highly likely to have CF.
• 85% of persons with CF have pancreatic insufficiency Plugs of mucus
reduce the digestive enzymes released from the pancreas causing mal-
digestion of food and malabsorption of nutrients.
• Decreased bicarbonate secretion reduces digestive enzyme activity.
• Decreased bile acid reabsorption contributes to fat malabsorption.
• Excessive mucus lining in the GI tract prevents nutrient absorption by
the microvilli.
GASTROINTESTINAL COMPLICATIONS
• Bulky, foul-smelling stools
• Cramping and intestinal obstruction
• Pancreatic damage causes impaired glucose tolerance
• (50% of adults with CF) and development of diabetes
COMMON TREATMENTS
Pancreatic enzyme replacement
• Adjust macronutrients for symptoms
• Nutrients for growth
• Meconium ileus causes the intestinal obstruction So, enzymes, fiber, fluids, exercise,
stool softeners are given.
Digestive Enzymes:
• Enteric-coated enzyme microspheres withstand acidic environment of the stomach,
they release enzymes in the duodenum, where they digest protein, fat and
carbohydrate.
NUTRITIONAL CARE GOALS
• Control malabsorption.
• Provide adequate nutrients for growth or maintain weight for
height or pulmonary function.
• Prevent nutritional deficiencies.
In children energy requirement should be based on the weigh gain and
growth.
Energy need for CF children without ventilation are comparable to
healthy children (100 – 110% of RDA).
In case of significant lung disease, malabsorption, ER increase 120 -
150% of RDA
Medical Nutrition Therapy
Protein Requirement:
Protein needs are increased in CF due to malabsorption
If energy needs are met, protein needs are usually met by
following 15-20% protein or use RDA
Or 2.2/kg b/w
Fat Requirement:
• Fat intake 35-40% of calories (in fat malabsorption), as tolerated
• Helps provide required energy, essential fatty acids and fat-soluble
vitamins.
• Limits volume of food needed to meet energy demands and improves
palatability of the diet
• Essential Fatty Acids deficiency sometimes occurs in CF patients
despite intake and pancreatic enzymes.
• Fat restriction is not recommended
• Important energy sources, fat used = MCT oil, fish oil.
CHO Requirement :
• Eventually intake may need to be modified if glucose intolerance
develops.
• Some patients develop lactose intolerance.
Vitamins requirement:
• With pancreatic enzymes, water soluble vitamins usually adequately
absorbed with daily multivitamin will need high potency
supplementation of fat soluble vitamins (A, D, K, E)
FEEDING STRATEGIES: INFANTS
• Breast feeding with supplements of high-calorie formulas and
pancreatic enzymes.
• Calorie dense infant formulas (20-27 kcals/oz) with enzymes.
• Protein hydrolysate formulas with MCT oil if needed.
FEEDING STRATEGIES: CHILDREN
ANDADULTS
• Regular mealtimes
• Large portions
• Extra snacks
• Nutrient-dense foods
• Nocturnal enteral feedings
• Intact or hydrolyzed formulas
• Add enzyme powder to feeding or take before and during
PNEUMONIA
It is a infection in the lungs caused by the microbe invasion in lungs. It causes
inflammation of air sacs.
Bacterial Pneumonia
• Streptococcus Pneumoniae
• Mycoplasma Pneumoniae
• Staphylococcus Aureus
Viral Pneumonia
• Haemophilus Influenzae
Alveoli fill with pus and fluid making gas exchange difficult.
Air Passage in Lungs
Defense System of Lungs
Hospital Acquired
Pneumonia
(Nosocomial)
• A person gets it when he
is admitted in the hospital
with any other disease
condition.
• Microbes in hospitals are
more antibiotic resistant.
• Example: MRSA
Community Acquired
Pneumonia
• A person gets it outside a
hospital setting, either from
the environment.
• The infection causes
deterioration of lung
resulting in fluid
accumulation and breathing
difficulties.
Types and Occurrence of Pneumonia
Ventilator Acquired
Pneumonia
• It is a subset of
Hospital acquired
pneumonia.
• It happens when a
person is on ventilator.
Aspiration Pneumonia
• Aspiration is when a Food,
Drugs, Gastric Content
passes into the trachea.
• Material like, saliva, nasal
secretion, bacteria, foods.
• The food items have
microorganisms on it that
causes infection which
ultimately leads to
pneumonia.
Sign and Symptoms
• Dyspnea [shortness of breath]
• Confusion
• Chest Pain
• Productive cough
• Fatigue
• Fever/ Sweating
• Chills
• Nausea, vomiting
Diagnosis
• Breathing Issues [shortness of
breath]
• Chest X-ray
• Tactile Vocal Fremitus
[More vibrations from back]
• Bronchial breath sounds
Treatment
•Anti-biotics
•Cough suppressants
•Pain Medications
NUTRITION IMPLICATION
Patients admitted to the hospital due to CAP (community acquired
Pneumonia), most important risk factor associated to mortality.
• Low serum albumin (<3.0 g/dl)
• The depress albumin is associated to the inflammation response rather
than malnutrition.
Other indices of poor nutrition status associate to death are low triceps
skinfold (TSF) and low BMI.
Medical Nutrition Therapy
• Energy required is based on the underlying diseases (often hypermetabolic/ Elevate
Resting Energy Expenditure), 1.2 – 1.4 x BEE.
REMEMBER do not over feed the patient.
• Overfeeding Increase CO2 production.
• The provision 25 kcal/kg appears to be adequate to most pt.
• Protein requirement: 1.2 – 1.5 g/kg.
• CHO may be given according to pt. needs.
• Fluid balanced should be monitor closely as pulmonary effusion can occur.
• Pulmonary edema, the use of fluid restricted enteral formulation (1.5 – 2 kcal/cc)
may be helpful, for those need for fluid restriction.
• Supplementation of potassium, calcium, and magnesium may be administered as
these are lost in the urine.
• Among the pulmonary infections with nutritional implications is pneumonia.
The role of vitamin A in treating pneumonia yields some possible results.
• Because of their role in inflammation and immunity, epidemiologic researches
investigating the role of EFAs. Such research shows a possible protective effect
against pneumonia by the ingestion of a-linolenic and linoleic acids.
• Pneumonia usually occurs as a nosocomial infection or as a consequences of
aspiration of food, fluid, or secretions such as saliva.
• Optimal nutrition status and proper feeding techniques aid in preventing this
pulmonary infection. Aspiration is common in infants, children, and adults who
are frail, have frequent coughing spasms, are unable to effectively chew or
swallow their foods and beverages or have inadequate head and neck control
during eating.
RESPIRATORY FAILURE
In respiratory failure, the gas exchange between the air and circulating blood is severely impaired,
resulting in abnormal levels of tissue gases that can be life threatening.
The normal value of arterial partial pressure of oxygen and carbon dioxide is,
PAO2: 10.6 -13.3kPa
PACO2: 4.7 -6.0 kPa
Hypoxemia: PAO2: < 10.6 kPa
Hypercapnia: PACO2: >6 Kpa
Respiratory failure
PAO2: <8kPa
PACO2: >6.7 kPa
Causes Of RF:
Any of a large number of conditions that cause lung injury or impair lung function can be the
underlying cause of failure; examples include infection (such as pneumonia or sepsis), physical
trauma, neuromuscular disorders, smoke inhalation, and airway obstruction.
Occur when the respiratory system is no longer able to perform its normal function.
It result from long standing chronic lung disease like COPD, CF or as a result of an acute abuse
to the lung such as acute respiratory distress syndrome (ARDS).
Categories of acute respiratory distress syndrome:
• Directly cause injured to the lung e.g. Pneumonia, aspiration or inhalation injury.
• Indirectly cause injury precipitated by event outside the lung e.g. sepsis, trauma, or
pancreatitis.
Medical Nutrition Therapy
• Energy required is based on the underlying diseases (often hypermetabolic) 1.2 – 1.4
x BEE
* REMEMBER do not over feed the patient as it increases CO2 production
• Increase ventilator demand associated with overfeeding;
• Excess glucose administration (>5 mg/kg per min).
• The provision 25 kcal/kg appears to be adequate to most patient
• Fluid balanced should be monitor closely
• Protein requirement: 1.2 – 1.5 g/kg (to promote nitrogen retention without being
excessive)
• Pulmonary edema, the use of fluid restricted enteral formulation (1.5 – 2 kcal/cc)may
be helpful, for those need for fluid restriction.
•Acute respiratory distress is associate with production of oxygen free radical and
inflammatory mediators, recent study shows:
• EPA in fish oil and GLA in borage oil can reduce the severity of inflammatory injury.
• High level of antioxidant: α-tocopherol, β-carotene and vit C at higher level than
DRI
• Increase serum α-tocopherol, β-carotene & prevent further oxidative damage.
• Phosphate is essential for optimal pulmonary function and normal diaphragm
contraction.
• Hypophosphatemia increase hospital stay and dependence to ventilation. Need to
monitor phosphate and supplementation should be initiated in hypophosphatemia
TUBERCULOSIS
TUBERCULOSIS
Caused by a bacillus bacterium
Nutritional factors that increase risk of TB:
• Many patients are developing drug-resistant TB
• Nutritional factors that increase risk of TB:
• Protein-energy malnutrition: affects the immune system;
debate whether it is a cause or consequence of the disease
• Micronutrient deficiencies that affect immune function
(vitamin D, A, C, iron, zinc)
Nutritional consequences:
• Increased energy expenditure
• Loss of appetite and body weight
• Increase in protein catabolism leading to muscle breakdown
• Malabsorption causing diarrhea, loss of fluids, electrolytes
Medical Nutrition Therapy
• Energy: 35-40 kcals/kg of ideal body weight
• Protein: 1.2-1.5 grams/kg body weight, or 15% of energy or 75-100
grams/day
• Multivitamin-mineral supplement at 100-150% DRI.
• Provide energy dense foods to overcome overfeeding.
• Provide colorful fruits and vegetables rich in antioxidants.
• Foods rich in Vitamin A, C and E and Zinc.
Thank You!

More Related Content

What's hot

Tpn
TpnTpn
parenteral and enteral nutrition
parenteral and enteral nutritionparenteral and enteral nutrition
parenteral and enteral nutrition
Shima Ghavimi, MD
 
Nutrition in critically ill patients
Nutrition in critically ill patientsNutrition in critically ill patients
Nutrition in critically ill patients
Awaneesh Katiyar
 
NFMNT Chapter 16 Provide Nutrition Education
NFMNT Chapter 16 Provide Nutrition EducationNFMNT Chapter 16 Provide Nutrition Education
NFMNT Chapter 16 Provide Nutrition Education
KellyGCDET
 
NHHC chapter 15 ppt
NHHC chapter 15 pptNHHC chapter 15 ppt
NHHC chapter 15 ppt
KellyGCDET
 
Nutrition in icu
Nutrition in icuNutrition in icu
Nutrition in icu
Siti Azila
 
Carbohydrate Counting for insulin dose adjustment
Carbohydrate Counting for insulin dose adjustmentCarbohydrate Counting for insulin dose adjustment
Carbohydrate Counting for insulin dose adjustment
ltejas86
 
ADIME Note
ADIME NoteADIME Note
ADIME Note
Jamie Lingo
 
CHO COUNTING
CHO COUNTINGCHO COUNTING
CHO COUNTING
nutritionistrepublic
 
Daily minimum nutritional requirements of the critically ill
Daily minimum nutritional requirements of the critically illDaily minimum nutritional requirements of the critically ill
Daily minimum nutritional requirements of the critically ill
RalekeOkoye
 
Nutrition in icu
Nutrition in icuNutrition in icu
Nutrition in icu
Rahul Varshney
 
Chapter 15 Enteral and Parenteral Nutrition Support
Chapter 15 Enteral and Parenteral Nutrition Support Chapter 15 Enteral and Parenteral Nutrition Support
Chapter 15 Enteral and Parenteral Nutrition Support
KellyGCDET
 
NFMNT Chapter 13 Apply Standard Nutrition Care
NFMNT Chapter 13 Apply Standard Nutrition CareNFMNT Chapter 13 Apply Standard Nutrition Care
NFMNT Chapter 13 Apply Standard Nutrition Care
KellyGCDET
 
Case Study Presentation
Case Study PresentationCase Study Presentation
Case Study Presentation
Stephanie Bachmann
 
3. nutrition support
3. nutrition support3. nutrition support
3. nutrition support
Wan Hazirah
 
Nutrition in Chronic Respiratory Diseases.ppt
Nutrition in Chronic Respiratory Diseases.pptNutrition in Chronic Respiratory Diseases.ppt
Nutrition in Chronic Respiratory Diseases.ppt
Dr Riham Hazem Raafat
 
Update on diabetes treatment strategies 2017
Update on diabetes treatment strategies 2017Update on diabetes treatment strategies 2017
Update on diabetes treatment strategies 2017
Indhu Reddy
 
Obesity Awareness
Obesity AwarenessObesity Awareness
Obesity Awareness
Sharanya Rajan
 
Intermittent fasting
Intermittent fastingIntermittent fasting
Intermittent fasting
fathi neana
 
Hyperglycemia management
Hyperglycemia managementHyperglycemia management
Hyperglycemia management
DrReshma Francis
 

What's hot (20)

Tpn
TpnTpn
Tpn
 
parenteral and enteral nutrition
parenteral and enteral nutritionparenteral and enteral nutrition
parenteral and enteral nutrition
 
Nutrition in critically ill patients
Nutrition in critically ill patientsNutrition in critically ill patients
Nutrition in critically ill patients
 
NFMNT Chapter 16 Provide Nutrition Education
NFMNT Chapter 16 Provide Nutrition EducationNFMNT Chapter 16 Provide Nutrition Education
NFMNT Chapter 16 Provide Nutrition Education
 
NHHC chapter 15 ppt
NHHC chapter 15 pptNHHC chapter 15 ppt
NHHC chapter 15 ppt
 
Nutrition in icu
Nutrition in icuNutrition in icu
Nutrition in icu
 
Carbohydrate Counting for insulin dose adjustment
Carbohydrate Counting for insulin dose adjustmentCarbohydrate Counting for insulin dose adjustment
Carbohydrate Counting for insulin dose adjustment
 
ADIME Note
ADIME NoteADIME Note
ADIME Note
 
CHO COUNTING
CHO COUNTINGCHO COUNTING
CHO COUNTING
 
Daily minimum nutritional requirements of the critically ill
Daily minimum nutritional requirements of the critically illDaily minimum nutritional requirements of the critically ill
Daily minimum nutritional requirements of the critically ill
 
Nutrition in icu
Nutrition in icuNutrition in icu
Nutrition in icu
 
Chapter 15 Enteral and Parenteral Nutrition Support
Chapter 15 Enteral and Parenteral Nutrition Support Chapter 15 Enteral and Parenteral Nutrition Support
Chapter 15 Enteral and Parenteral Nutrition Support
 
NFMNT Chapter 13 Apply Standard Nutrition Care
NFMNT Chapter 13 Apply Standard Nutrition CareNFMNT Chapter 13 Apply Standard Nutrition Care
NFMNT Chapter 13 Apply Standard Nutrition Care
 
Case Study Presentation
Case Study PresentationCase Study Presentation
Case Study Presentation
 
3. nutrition support
3. nutrition support3. nutrition support
3. nutrition support
 
Nutrition in Chronic Respiratory Diseases.ppt
Nutrition in Chronic Respiratory Diseases.pptNutrition in Chronic Respiratory Diseases.ppt
Nutrition in Chronic Respiratory Diseases.ppt
 
Update on diabetes treatment strategies 2017
Update on diabetes treatment strategies 2017Update on diabetes treatment strategies 2017
Update on diabetes treatment strategies 2017
 
Obesity Awareness
Obesity AwarenessObesity Awareness
Obesity Awareness
 
Intermittent fasting
Intermittent fastingIntermittent fasting
Intermittent fasting
 
Hyperglycemia management
Hyperglycemia managementHyperglycemia management
Hyperglycemia management
 

Similar to Nutrition Therapy in Pulmonary Diseases.pptx

CYSTIC FIBROSIS(1)respiratorysystem (1).pptx
CYSTIC FIBROSIS(1)respiratorysystem (1).pptxCYSTIC FIBROSIS(1)respiratorysystem (1).pptx
CYSTIC FIBROSIS(1)respiratorysystem (1).pptx
PrashantKoirala12
 
CYSTIC FIBROSresIsystemggghsddjjjS(1).pptx
CYSTIC FIBROSresIsystemggghsddjjjS(1).pptxCYSTIC FIBROSresIsystemggghsddjjjS(1).pptx
CYSTIC FIBROSresIsystemggghsddjjjS(1).pptx
PrashantKoirala11
 
CYSTIC FIBROSISrespiratory system(1).pptx
CYSTIC FIBROSISrespiratory system(1).pptxCYSTIC FIBROSISrespiratory system(1).pptx
CYSTIC FIBROSISrespiratory system(1).pptx
PrashantKoirala12
 
Cystic Fibrosis Jo.pptx
Cystic Fibrosis Jo.pptxCystic Fibrosis Jo.pptx
Cystic Fibrosis Jo.pptx
Jo Martin Kuncheria
 
Cystic fibrosis
Cystic fibrosisCystic fibrosis
Cystic fibrosis
HIRANGER
 
Nutrition in surgery
Nutrition in surgeryNutrition in surgery
Nutrition in surgery
drssp1967
 
cystic fibrosis STUDENT version
cystic fibrosis STUDENT versioncystic fibrosis STUDENT version
cystic fibrosis STUDENT version
Elva Van Devender, Ph.D., Pharm.D., BCPS
 
Cystic fibrosis
Cystic fibrosisCystic fibrosis
Cystic fibrosis
Sanil Varghese
 
cystic fibrosis
 cystic fibrosis cystic fibrosis
cystic fibrosis
DrSheika Bawazir
 
Nutrition in surgery
Nutrition in surgeryNutrition in surgery
Nutrition in surgery
Hidayat Shariff
 
231629962-Cystic-Fibrosis-1
231629962-Cystic-Fibrosis-1231629962-Cystic-Fibrosis-1
231629962-Cystic-Fibrosis-1
Sheikah Bawazir
 
Nutrition in COPD.pptx
Nutrition in COPD.pptxNutrition in COPD.pptx
Nutrition in COPD.pptx
Kumar Utsav
 
Cystic fibrosis
Cystic fibrosisCystic fibrosis
Cystic fibrosis
sangita8
 
1.mnt for pulmonary diseases
1.mnt for pulmonary diseases1.mnt for pulmonary diseases
1.mnt for pulmonary diseases
Wan Hazirah
 
Cystic fibrosis
Cystic fibrosis Cystic fibrosis
Cystic fibrosis
Rawalpindi Medical College
 
Total parenteral nutrition
Total parenteral nutritionTotal parenteral nutrition
Total parenteral nutrition
Priyatham Kasaraneni
 
Respiratory distress syndrome
Respiratory distress syndromeRespiratory distress syndrome
Respiratory distress syndrome
Binal Joshi
 
NUTRATIOrtttttttttttttttttttttttttttttttttN.pptx
NUTRATIOrtttttttttttttttttttttttttttttttttN.pptxNUTRATIOrtttttttttttttttttttttttttttttttttN.pptx
NUTRATIOrtttttttttttttttttttttttttttttttttN.pptx
MosaHasen
 
Nec by Dr Achumie
Nec by Dr AchumieNec by Dr Achumie
Nec by Dr Achumie
Victoria Achumie
 
Nutritioninicu 120119095954-phpapp02
Nutritioninicu 120119095954-phpapp02Nutritioninicu 120119095954-phpapp02
Nutritioninicu 120119095954-phpapp02
Dana Perez
 

Similar to Nutrition Therapy in Pulmonary Diseases.pptx (20)

CYSTIC FIBROSIS(1)respiratorysystem (1).pptx
CYSTIC FIBROSIS(1)respiratorysystem (1).pptxCYSTIC FIBROSIS(1)respiratorysystem (1).pptx
CYSTIC FIBROSIS(1)respiratorysystem (1).pptx
 
CYSTIC FIBROSresIsystemggghsddjjjS(1).pptx
CYSTIC FIBROSresIsystemggghsddjjjS(1).pptxCYSTIC FIBROSresIsystemggghsddjjjS(1).pptx
CYSTIC FIBROSresIsystemggghsddjjjS(1).pptx
 
CYSTIC FIBROSISrespiratory system(1).pptx
CYSTIC FIBROSISrespiratory system(1).pptxCYSTIC FIBROSISrespiratory system(1).pptx
CYSTIC FIBROSISrespiratory system(1).pptx
 
Cystic Fibrosis Jo.pptx
Cystic Fibrosis Jo.pptxCystic Fibrosis Jo.pptx
Cystic Fibrosis Jo.pptx
 
Cystic fibrosis
Cystic fibrosisCystic fibrosis
Cystic fibrosis
 
Nutrition in surgery
Nutrition in surgeryNutrition in surgery
Nutrition in surgery
 
cystic fibrosis STUDENT version
cystic fibrosis STUDENT versioncystic fibrosis STUDENT version
cystic fibrosis STUDENT version
 
Cystic fibrosis
Cystic fibrosisCystic fibrosis
Cystic fibrosis
 
cystic fibrosis
 cystic fibrosis cystic fibrosis
cystic fibrosis
 
Nutrition in surgery
Nutrition in surgeryNutrition in surgery
Nutrition in surgery
 
231629962-Cystic-Fibrosis-1
231629962-Cystic-Fibrosis-1231629962-Cystic-Fibrosis-1
231629962-Cystic-Fibrosis-1
 
Nutrition in COPD.pptx
Nutrition in COPD.pptxNutrition in COPD.pptx
Nutrition in COPD.pptx
 
Cystic fibrosis
Cystic fibrosisCystic fibrosis
Cystic fibrosis
 
1.mnt for pulmonary diseases
1.mnt for pulmonary diseases1.mnt for pulmonary diseases
1.mnt for pulmonary diseases
 
Cystic fibrosis
Cystic fibrosis Cystic fibrosis
Cystic fibrosis
 
Total parenteral nutrition
Total parenteral nutritionTotal parenteral nutrition
Total parenteral nutrition
 
Respiratory distress syndrome
Respiratory distress syndromeRespiratory distress syndrome
Respiratory distress syndrome
 
NUTRATIOrtttttttttttttttttttttttttttttttttN.pptx
NUTRATIOrtttttttttttttttttttttttttttttttttN.pptxNUTRATIOrtttttttttttttttttttttttttttttttttN.pptx
NUTRATIOrtttttttttttttttttttttttttttttttttN.pptx
 
Nec by Dr Achumie
Nec by Dr AchumieNec by Dr Achumie
Nec by Dr Achumie
 
Nutritioninicu 120119095954-phpapp02
Nutritioninicu 120119095954-phpapp02Nutritioninicu 120119095954-phpapp02
Nutritioninicu 120119095954-phpapp02
 

Recently uploaded

Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
Earlene McNair
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
NephroTube - Dr.Gawad
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
rishi2789
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Dr. Rabia Inam Gandapore
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
rishi2789
 
All info about Diabetes and how to control it.
 All info about Diabetes and how to control it. All info about Diabetes and how to control it.
All info about Diabetes and how to control it.
Gokuldas Hospital
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
NX Healthcare
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
MedicoseAcademics
 
Identifying Major Symptoms of Slip Disc.
 Identifying Major Symptoms of Slip Disc. Identifying Major Symptoms of Slip Disc.
Identifying Major Symptoms of Slip Disc.
Gokuldas Hospital
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
rishi2789
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
ZayedKhan38
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
Dr. Ahana Haroon
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
Josep Vidal-Alaball
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
Dr. Jyothirmai Paindla
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
PsychoTech Services
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
Dhayanithi C
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
taiba qazi
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
Dr. Jyothirmai Paindla
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
Health Advances
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
HongBiThi1
 

Recently uploaded (20)

Chapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptxChapter 11 Nutrition and Chronic Diseases.pptx
Chapter 11 Nutrition and Chronic Diseases.pptx
 
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.GawadHemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
Hemodialysis: Chapter 5, Dialyzers Overview - Dr.Gawad
 
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdfCHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
CHEMOTHERAPY_RDP_CHAPTER 4_ANTI VIRAL DRUGS.pdf
 
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptxEar and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
Ear and its clinical correlations By Dr. Rabia Inam Gandapore.pptx
 
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdfCHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
CHEMOTHERAPY_RDP_CHAPTER 3_ANTIFUNGAL AGENT.pdf
 
All info about Diabetes and how to control it.
 All info about Diabetes and how to control it. All info about Diabetes and how to control it.
All info about Diabetes and how to control it.
 
Top Travel Vaccinations in Manchester
Top Travel Vaccinations in ManchesterTop Travel Vaccinations in Manchester
Top Travel Vaccinations in Manchester
 
The Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic PrinciplesThe Electrocardiogram - Physiologic Principles
The Electrocardiogram - Physiologic Principles
 
Identifying Major Symptoms of Slip Disc.
 Identifying Major Symptoms of Slip Disc. Identifying Major Symptoms of Slip Disc.
Identifying Major Symptoms of Slip Disc.
 
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
CHEMOTHERAPY_RDP_CHAPTER 2 _LEPROSY.pdf1
 
pathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathologypathology MCQS introduction to pathology general pathology
pathology MCQS introduction to pathology general pathology
 
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USENARCOTICS- POLICY AND PROCEDURES FOR ITS USE
NARCOTICS- POLICY AND PROCEDURES FOR ITS USE
 
Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)Artificial Intelligence Symposium (THAIS)
Artificial Intelligence Symposium (THAIS)
 
Journal Article Review on Rasamanikya
Journal Article Review on RasamanikyaJournal Article Review on Rasamanikya
Journal Article Review on Rasamanikya
 
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotesPromoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
Promoting Wellbeing - Applied Social Psychology - Psychology SuperNotes
 
Ketone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistryKetone bodies and metabolism-biochemistry
Ketone bodies and metabolism-biochemistry
 
Tests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptxTests for analysis of different pharmaceutical.pptx
Tests for analysis of different pharmaceutical.pptx
 
Role of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of HyperthyroidismRole of Mukta Pishti in the Management of Hyperthyroidism
Role of Mukta Pishti in the Management of Hyperthyroidism
 
Cell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune DiseaseCell Therapy Expansion and Challenges in Autoimmune Disease
Cell Therapy Expansion and Challenges in Autoimmune Disease
 
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấuK CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
K CỔ TỬ CUNG.pdf tự ghi chép, chữ hơi xấu
 

Nutrition Therapy in Pulmonary Diseases.pptx

  • 2. CYSTIC FIBROSIS (CF) Cystic fibrosis is a genetic condition. It's caused by a gene mutation in [cystic fibrosis transmembrane conductance regulatory gene CFTR/ chromosome no.7]. The gene mutation affects the movement of salt and water in and out of cells. This, along with recurrent infections, can result in a build-up of thick, sticky mucus in the body's tubes and passageways – particularly the lungs and digestive system. • Inherited autosomal recessive disorder • CF incidence of 1:2500 live births • Survival is improving; median age of patients has exceeded 30 years • Epithelial cells and exocrine glands secrete abnormal mucus (thick) • Affects respiratory tract, sweat, salivary, intestine, pancreas, liver, reproductive tract
  • 3.
  • 4. Organs Affected by Cystic Fibrosis • Lungs • Sinus • Intestines • Panaceas • Liver
  • 5. Symptoms • The dysfunctional CFTR protein channel is found all over GI tract • It causes elevated Sweat- Electrolyte balance. • A persistent cough that produces thick mucus (sputum) • Wheezing • Exercise intolerance • Repeated lung infections • Inflamed nasal passages or a stuffy nose • Recurrent sinusitis
  • 6. DIAGNOSIS OF CYSTIC FIBROSIS • Neonatal screening provides opportunity to prevent malnutrition in CF infants • Sweat test (Na and Cl >60 mEq /L) • Chronic lung disease • Malabsorption • Family history
  • 7. Complications of CF • Damaged airways • Coughing up blood (hemoptysis) • Chronic infections • Pneumothorax • Respiratory failure
  • 8. NUTRITIONAL IMPLICATIONS OF CF • Infants born with meconium ileus are highly likely to have CF. • 85% of persons with CF have pancreatic insufficiency Plugs of mucus reduce the digestive enzymes released from the pancreas causing mal- digestion of food and malabsorption of nutrients. • Decreased bicarbonate secretion reduces digestive enzyme activity. • Decreased bile acid reabsorption contributes to fat malabsorption. • Excessive mucus lining in the GI tract prevents nutrient absorption by the microvilli.
  • 9. GASTROINTESTINAL COMPLICATIONS • Bulky, foul-smelling stools • Cramping and intestinal obstruction • Pancreatic damage causes impaired glucose tolerance • (50% of adults with CF) and development of diabetes
  • 10. COMMON TREATMENTS Pancreatic enzyme replacement • Adjust macronutrients for symptoms • Nutrients for growth • Meconium ileus causes the intestinal obstruction So, enzymes, fiber, fluids, exercise, stool softeners are given. Digestive Enzymes: • Enteric-coated enzyme microspheres withstand acidic environment of the stomach, they release enzymes in the duodenum, where they digest protein, fat and carbohydrate.
  • 11. NUTRITIONAL CARE GOALS • Control malabsorption. • Provide adequate nutrients for growth or maintain weight for height or pulmonary function. • Prevent nutritional deficiencies.
  • 12. In children energy requirement should be based on the weigh gain and growth. Energy need for CF children without ventilation are comparable to healthy children (100 – 110% of RDA). In case of significant lung disease, malabsorption, ER increase 120 - 150% of RDA Medical Nutrition Therapy
  • 13. Protein Requirement: Protein needs are increased in CF due to malabsorption If energy needs are met, protein needs are usually met by following 15-20% protein or use RDA Or 2.2/kg b/w
  • 14. Fat Requirement: • Fat intake 35-40% of calories (in fat malabsorption), as tolerated • Helps provide required energy, essential fatty acids and fat-soluble vitamins. • Limits volume of food needed to meet energy demands and improves palatability of the diet • Essential Fatty Acids deficiency sometimes occurs in CF patients despite intake and pancreatic enzymes. • Fat restriction is not recommended • Important energy sources, fat used = MCT oil, fish oil.
  • 15. CHO Requirement : • Eventually intake may need to be modified if glucose intolerance develops. • Some patients develop lactose intolerance. Vitamins requirement: • With pancreatic enzymes, water soluble vitamins usually adequately absorbed with daily multivitamin will need high potency supplementation of fat soluble vitamins (A, D, K, E)
  • 16. FEEDING STRATEGIES: INFANTS • Breast feeding with supplements of high-calorie formulas and pancreatic enzymes. • Calorie dense infant formulas (20-27 kcals/oz) with enzymes. • Protein hydrolysate formulas with MCT oil if needed.
  • 17. FEEDING STRATEGIES: CHILDREN ANDADULTS • Regular mealtimes • Large portions • Extra snacks • Nutrient-dense foods • Nocturnal enteral feedings • Intact or hydrolyzed formulas • Add enzyme powder to feeding or take before and during
  • 18. PNEUMONIA It is a infection in the lungs caused by the microbe invasion in lungs. It causes inflammation of air sacs. Bacterial Pneumonia • Streptococcus Pneumoniae • Mycoplasma Pneumoniae • Staphylococcus Aureus Viral Pneumonia • Haemophilus Influenzae
  • 19. Alveoli fill with pus and fluid making gas exchange difficult.
  • 20. Air Passage in Lungs
  • 22. Hospital Acquired Pneumonia (Nosocomial) • A person gets it when he is admitted in the hospital with any other disease condition. • Microbes in hospitals are more antibiotic resistant. • Example: MRSA Community Acquired Pneumonia • A person gets it outside a hospital setting, either from the environment. • The infection causes deterioration of lung resulting in fluid accumulation and breathing difficulties. Types and Occurrence of Pneumonia
  • 23. Ventilator Acquired Pneumonia • It is a subset of Hospital acquired pneumonia. • It happens when a person is on ventilator. Aspiration Pneumonia • Aspiration is when a Food, Drugs, Gastric Content passes into the trachea. • Material like, saliva, nasal secretion, bacteria, foods. • The food items have microorganisms on it that causes infection which ultimately leads to pneumonia.
  • 24. Sign and Symptoms • Dyspnea [shortness of breath] • Confusion • Chest Pain • Productive cough • Fatigue • Fever/ Sweating • Chills • Nausea, vomiting
  • 25. Diagnosis • Breathing Issues [shortness of breath] • Chest X-ray • Tactile Vocal Fremitus [More vibrations from back] • Bronchial breath sounds Treatment •Anti-biotics •Cough suppressants •Pain Medications
  • 26. NUTRITION IMPLICATION Patients admitted to the hospital due to CAP (community acquired Pneumonia), most important risk factor associated to mortality. • Low serum albumin (<3.0 g/dl) • The depress albumin is associated to the inflammation response rather than malnutrition. Other indices of poor nutrition status associate to death are low triceps skinfold (TSF) and low BMI.
  • 27. Medical Nutrition Therapy • Energy required is based on the underlying diseases (often hypermetabolic/ Elevate Resting Energy Expenditure), 1.2 – 1.4 x BEE. REMEMBER do not over feed the patient. • Overfeeding Increase CO2 production. • The provision 25 kcal/kg appears to be adequate to most pt. • Protein requirement: 1.2 – 1.5 g/kg. • CHO may be given according to pt. needs. • Fluid balanced should be monitor closely as pulmonary effusion can occur. • Pulmonary edema, the use of fluid restricted enteral formulation (1.5 – 2 kcal/cc) may be helpful, for those need for fluid restriction. • Supplementation of potassium, calcium, and magnesium may be administered as these are lost in the urine.
  • 28. • Among the pulmonary infections with nutritional implications is pneumonia. The role of vitamin A in treating pneumonia yields some possible results. • Because of their role in inflammation and immunity, epidemiologic researches investigating the role of EFAs. Such research shows a possible protective effect against pneumonia by the ingestion of a-linolenic and linoleic acids. • Pneumonia usually occurs as a nosocomial infection or as a consequences of aspiration of food, fluid, or secretions such as saliva. • Optimal nutrition status and proper feeding techniques aid in preventing this pulmonary infection. Aspiration is common in infants, children, and adults who are frail, have frequent coughing spasms, are unable to effectively chew or swallow their foods and beverages or have inadequate head and neck control during eating.
  • 29. RESPIRATORY FAILURE In respiratory failure, the gas exchange between the air and circulating blood is severely impaired, resulting in abnormal levels of tissue gases that can be life threatening. The normal value of arterial partial pressure of oxygen and carbon dioxide is, PAO2: 10.6 -13.3kPa PACO2: 4.7 -6.0 kPa Hypoxemia: PAO2: < 10.6 kPa Hypercapnia: PACO2: >6 Kpa Respiratory failure PAO2: <8kPa PACO2: >6.7 kPa
  • 30. Causes Of RF: Any of a large number of conditions that cause lung injury or impair lung function can be the underlying cause of failure; examples include infection (such as pneumonia or sepsis), physical trauma, neuromuscular disorders, smoke inhalation, and airway obstruction. Occur when the respiratory system is no longer able to perform its normal function. It result from long standing chronic lung disease like COPD, CF or as a result of an acute abuse to the lung such as acute respiratory distress syndrome (ARDS). Categories of acute respiratory distress syndrome: • Directly cause injured to the lung e.g. Pneumonia, aspiration or inhalation injury. • Indirectly cause injury precipitated by event outside the lung e.g. sepsis, trauma, or pancreatitis.
  • 31. Medical Nutrition Therapy • Energy required is based on the underlying diseases (often hypermetabolic) 1.2 – 1.4 x BEE * REMEMBER do not over feed the patient as it increases CO2 production • Increase ventilator demand associated with overfeeding; • Excess glucose administration (>5 mg/kg per min). • The provision 25 kcal/kg appears to be adequate to most patient • Fluid balanced should be monitor closely • Protein requirement: 1.2 – 1.5 g/kg (to promote nitrogen retention without being excessive) • Pulmonary edema, the use of fluid restricted enteral formulation (1.5 – 2 kcal/cc)may be helpful, for those need for fluid restriction.
  • 32. •Acute respiratory distress is associate with production of oxygen free radical and inflammatory mediators, recent study shows: • EPA in fish oil and GLA in borage oil can reduce the severity of inflammatory injury. • High level of antioxidant: α-tocopherol, β-carotene and vit C at higher level than DRI • Increase serum α-tocopherol, β-carotene & prevent further oxidative damage. • Phosphate is essential for optimal pulmonary function and normal diaphragm contraction. • Hypophosphatemia increase hospital stay and dependence to ventilation. Need to monitor phosphate and supplementation should be initiated in hypophosphatemia
  • 34.
  • 35. TUBERCULOSIS Caused by a bacillus bacterium
  • 36.
  • 37. Nutritional factors that increase risk of TB: • Many patients are developing drug-resistant TB • Nutritional factors that increase risk of TB: • Protein-energy malnutrition: affects the immune system; debate whether it is a cause or consequence of the disease • Micronutrient deficiencies that affect immune function (vitamin D, A, C, iron, zinc)
  • 38. Nutritional consequences: • Increased energy expenditure • Loss of appetite and body weight • Increase in protein catabolism leading to muscle breakdown • Malabsorption causing diarrhea, loss of fluids, electrolytes
  • 39. Medical Nutrition Therapy • Energy: 35-40 kcals/kg of ideal body weight • Protein: 1.2-1.5 grams/kg body weight, or 15% of energy or 75-100 grams/day • Multivitamin-mineral supplement at 100-150% DRI. • Provide energy dense foods to overcome overfeeding. • Provide colorful fruits and vegetables rich in antioxidants. • Foods rich in Vitamin A, C and E and Zinc.

Editor's Notes

  1. CFTR gene codes CFTR protein – which is a chloride channel – It help the ions to move in and out. Epithelial cells are the cells that covers inside and outside surface of body
  2. Inflammation and infection of sinus. As it effects the Epithelium layer in upper respiratory tract. The mucous blocks the digestive enzymes from reaching the intestines. So Fats and proteins are not digested properly. Pancreas and Intestines cant work properly
  3. Whistling sounds while breathing
  4. The dark green substance forming the first faeces of a newborn infant. Meconium ileus is a bowel obstruction that occurs when the meconium in your child's intestine is even thicker and stickier than normal meconium, creating a blockage in a part of the small intestine called the ileum. Most infants with meconium ileus have a disease called cystic fibrosis.
  5. Fat soluble vitamins.
  6. Inflammatory response– WBS, protein, fluid and WBC
  7. Inflammation can cause fluid retention in alveoli
  8. Alveoli are tiny air sacks in grape like structure that has capillaries in it. The gas exchange occurs in alveoli.
  9. With the air we inhale certain microorganisms. Mucociliary escalator has tiny villi that structure that prevents the micrograms. Macrophages engulfs the microorganisms.
  10. sthethoscope
  11. Protein needs are increased in patients with lung inflammation or Acute Respiratory Distress Syndrome. For mild or moderate lung injury, protein recommendations range from 1.0 to 1.5 grams of protein per kilogram body weight per day
  12. a-linolenic and linoleic acids is present in sunflower seeds, nuts, soybean, canola oil. EFAs [essential fatty acids]
  13. The rate of oxygen diffusion across the alveoli capillary membrane with respect to elimination of co2 Movement of substance from higher concentration to a lower conc. ARTERIAL BLOOD GAS TEST
  14. Protein needs are increased in patients with lung inflammation or ARDS. For mild or moderate lung injury, protein recommendations range from 1.0 to 1.5 grams of protein per kilogram body weight per day
  15. Gama Linoleic acid Goazban Alpha tocopherol: prevents blood clotting, anti oxidant [free radical damage] Beta carotene : Anti oxidant